Join the Duke-Margolis Center for Health Policy—including an introduction by former FDA Commissioners Dr. Mark McClellan and Dr. Scott Gottlieb—for an important discussion on combating rising antimicrobial resistance (AMR) in the context of U.S. public health preparedness, support for novel antibiotics, global AMR policy leadership, and emerging multi-sector innovation.

Rising antimicrobial resistance remains a top global public health threat and efforts to support novel antibiotic development and availability are more critical and timely than ever. As the ongoing pandemic centers national and global conversations around actions to prevent and combat future infectious disease threats, the time to take action against AMR is now.

CARB-X participants include Kevin Outterson, Executive Director, who will join the panel for Session 2: Global Policy Leadership and Proposals to Combat AMR at 11:25AM ET.  This session will highlight how the U.S. can lead policy approaches to combat AMR through existing legislative proposals and opportunities to coordinate domestic
actions with existing international efforts. 

Click here to learn more.
Click here to view the agenda.
Click here to register.